NexImmune EVP, Head of Research & Development Jerome Zeldis receives $4.3M in 2021

NexImmune reports 2021 executive compensation

By ExecPay News

Published: April 4, 2023

NexImmune reported fiscal year 2021 executive compensation information on April 4, 2023.
In 2021, four NexImmune executives received on average a compensation package of $2.8M, a 329% increase compared to previous year.
Average pay of disclosed executives at NexImmune
Jerome Zeldis, EVP, Head of Research & Development, received $4.3M in total. 91% of Zeldis' compensation, or $3.9M, was in option awards. Zeldis also received $396K in salary and $9.8K in other compensation.
Scott Carmer, Chief Executive Officer, received a compensation package of $4.3M, which increased by 730% compared to previous year. 83% of the compensation package, or $3.6M, was in option awards.
Kristi Jones, Chief Operating Officer, earned $1.5M in 2021, a 279% increase compared to previous year.
John Trainer, Chief Financial Officer, received $854K in 2021, which decreases by 15% compared to 2020.

Related executives

Jerome Zeldis

NexImmune

EVP, Head of Research & Development

Scott Carmer

NexImmune

Chief Executive Officer

Kristi Jones

NexImmune

Chief Executive Officer

John Trainer

NexImmune

Chief Financial Officer

You may also like

Source: SEC filing on April 4, 2023.